EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the therapeutic potential of metal complexes in glioblastoma treatment: a focus on brain tumor targeting strategies

Nimer F. Alsabeelah

Reviews in Inorganic Chemistry · 25.11.2026 · 46 (4) · 641-656

DOI: 10.1515/revic-2025-0080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reviews in Inorganic Chemistry, online erschienen am 12.01.2026. Verfasst von Nimer F. Alsabeelah. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is one of the most aggressive and fatal brain tumors in adults, marked by high recurrence rates, poor prognosis, and a median survival of less than 5 %. Its treatment remains a major challenge due to resistance to conventional therapies and the difficulty of crossing the blood-brain barrier (BBB). Despite advancements in surgery, radiation, and chemotherapy, GBM’s prognosis remains dismal. This study highlights the emerging potential of metal complexes as therapeutic agents against GBM. Compounds based on metals like ruthenium (Ru), copper (Cu), gold (Au), and platinum (Pt) have shown the ability to induce cytotoxicity through DNA interaction, oxidative stress, and apoptosis. Notably, in U-251 cells, compounds C45 (0.51 µM), C46 (0.49 µM), C47 (0.29 µM), and C52 (0.25 µM) demonstrated strong potency. In U-87 MG cells, C53 (15.72 nM) and C54 (8.48 nM) were particularly effective. Meanwhile, LN229 cells responded moderately to C77 (1.80 µM), C79 (0.88 µM), and C80 (0.96 µM). These findings suggest that U-251 and U-87 MG cells are more responsive to these metal complexes. Overall, the study underscores the promise of metal-based therapeutics in overcoming the BBB and drug resistance, offering a pathway toward safer, more effective, and environmentally conscious GBM treatments.

Zitieren

APA

Alsabeelah, N. F. (2026). Exploring the therapeutic potential of metal complexes in glioblastoma treatment: a focus on brain tumor targeting strategies. Reviews in Inorganic Chemistry, 46(4), 641-656. https://doi.org/10.1515/revic-2025-0080

Vancouver

Alsabeelah NF. Exploring the therapeutic potential of metal complexes in glioblastoma treatment: a focus on brain tumor targeting strategies. Reviews in Inorganic Chemistry. 2026;46(4):641-656. doi:10.1515/revic-2025-0080

BibTeX
@article{Alsabeelah2026,
  author = {Alsabeelah, Nimer F.},
  title = {Exploring the therapeutic potential of metal complexes in glioblastoma treatment: a focus on brain tumor targeting strategies},
  journal = {Reviews in Inorganic Chemistry},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {641--656},
  doi = {10.1515/revic-2025-0080}
}
Kostenlos starten →